Our case report is an example of the presentation, diagnosis, and management of MIS-A. As we dove into the literature and discovered other documented cases of MIS-A, we created Figure 1 to illustrate the similarities and differences when compared with Kawasaki-like multisystem inflammatory syndrome. Our research into previous case reports illustrates the wide range of presentations, degree of end-organ damage, and treatment modalities. This diagnosis needs to be considered in the presence of recent COVID infection with new onset end organ failure, as prompt diagnosis and treatment is crucial for better outcomes.
MIS-A: Multisystem inflammatory syndrome in adults; ED: Emergency department; ICU: Intensive care unit; IVIG: Intravenous immunoglobulin; BMI: Body mass index; PCR: Polymerase chain reaction; CT: Computed tomography; POCUS: Point of care ultrasound; CRP: C-reactive protein; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; BNP: Brain natriuretic peptide; CDC: Centers for Disease Control; ESR: Erythrocyte sedimentation rate; IL-6: Interleukin-6.
No funding was received for this study.
Availability of data and materials
Ethics approval and consent to participate
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Consent for publication
Written informed consent was obtained from the patient for publication of this care report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
J Med Case Reports. 2022;16(102) © 2022 BioMed Central, Ltd.